NewAmsterdam Pharma Company
NAMS
#3710
Rank
NZ$6.14 B
Marketcap
NZ$54.18
Share price
-0.57%
Change (1 day)
27.74%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.45 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total debt is NZ$0.45 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

NewAmsterdam Pharma Company - Total debt on balance sheet (from 2022 to 2023)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.79 M737.26%
2023-12-31NZ$0.09 M-52.19%
2022-12-31NZ$0.19 M-35.54%
2021-12-31NZ$0.3 M-98.74%
2020-12-31NZ$24.42 M